We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Genticel Launches its Phase II Trial in Women Infected with High-Risk HPV

News   Mar 06, 2014

 
Genticel Launches its Phase II Trial in Women Infected with High-Risk HPV
 
 
 

RELATED ARTICLES

Shortcut to Recreating Key HIV Antibody for Vaccines

News

A portion of the roadmap toward effective neutralization of HIV has been clarified, identifying the steps that a critical HIV antibody takes to develop and maintain its ability to neutralize the virus.

READ MORE

Drug Cocktail Cripples Cancer Cells

News

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

READ MORE

Repurposing Breast Cancer Drug to Help Treat Pancreatic Cancer

News

The well-known drug tamoxifen could exploit a weakness in the physical ‘scaffolds’ around tumors, according to research led by Imperial.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE